A Trusted Advisor to Global Cannabis and Psychopharmacology Companies Our combined experience in the Cannabis, psychopharmacology and Life science/Biotech sectors helps us confidently close strategic and financing transactions that match the near- and long-term goals of our clients. We specialize finding the right transaction – mergers, acquisitions, reverse mergers, equity and debt financings and incremental transactions such as licensing, joint ventures and co-development arrangements – to not only help our clients survive but thrive.
Golden Eagle Partners的外部链接
US，CO，Denver，80228
As we continue our GEP Global Interactive Webinars, we want to ensure our discussions are as valuable and relevant to you as possible. Your insights will help us shape our upcoming sessions to meet your unique interests and needs. Your feedback is invaluable, and we appreciate your time in helping us craft impactful discussions.
此处无法显示此内容
在领英 APP 中访问此内容等
Golden Eagle Partners’ (GEP) Global Interactive Webinar: Avecho – Sandoz Deal The Golden Eagle Partners’ team (https://lnkd.in/giEaftZe) was over the moon today to welcome one of our favorite people in Cannabis to our third Global Interactive Webinar (GIW) of 2025 with Paul Gavin, PhD. Below is the time map, link and password to the Zoom webinar. I hope you enjoy it…we found it to be a unique conversation. Link to Recording https://lnkd.in/gzwnZ94M Passcode: =?9#otFv ? Time Map and Topics 0:00 – GEP introduction 2:15 – Paul Gavin introduction 3:30 – GW Pharma and Avecho Biotech – any similarities? 5:00 – Recent history of Australian medical Cannabis and the TGA 10:00 – Avecho’s pivotal trial design 12:40 – The Sandoz deal explained 15:00 – International implications for an Australian pivotal trial 15:50 – The Sandoz collaboration economics 17:00 – Words of recommendation from Paul 21:30 – Does this change things? 23:00 – What is one characteristic of yours that has helped you succeed?
Avecho Biotechnology and Sandoz Collaboration - Pharma and Cannabis Golden Eagle Partners (GEP) is excited to announce the third installment of our 2025 Global Interactive Webinar Series featuring special guest, Paul Gavin, PhD, CEO of Avecho Biotechnology Limited (ASX:AVE). A week ago today, Avecho (avecho.com.au) signed one of the most groundbreaking agreements in the history of global Cannabis with an exclusive, development agreement with Sandoz AG (www.sandoz.com). https://lnkd.in/eQtkEUnT You want to learn more about the details of this collaboration between Avecho and Sandoz, join us this Wednesday March 12th for our interactive webinar with at 800 SAST/ 1400 PT/1500 MT/ 1700 ET/ 2300 CET/2400 IST. Best, David #Cannabis #pharma #TGA #clinicaltrials #innovation #sandoz #avecho
Conversation with Paul Gavin, PhD and CEO of Avecho Biotechnology after their Groundbreaking Deal with Sandoz The Golden Eagle Partners (https://lnkd.in/giEaftZe) team would like to announce the third installment for 2025 of the Golden Eagle Partners (GEP) Global Interactive Webinar Series. We will welcome Paul Gavin, PhD to our webinar next Wednesday, March 12th at 1400 PT/1500 MT/1700 ET/2300 CET/2400 IST/700 SAST. Our webinar is meant to integrate GEP’s over nine years of worldwide Cannabis expertise with perspectives from leaders from all over the globe into a lively and interactive 24-minute (420 backwards) discussion. Avecho Biotechnology Limited (ASX: AVE) team announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG for the commercial rights to Avecho's Phase III cannabidiol ("CBD") capsule for insomnia in Australia.??Below is a link to the press release. https://lnkd.in/gcAyKfDq Register in advance for this webinar: https://lnkd.in/gfa45QeJ We hope to see you there!
Golden Eagle Partners’ (GEP) Global Interactive Webinar with Jeff Raber, PhD David W. Traylor and the Golden Eagle Partners’ (https://lnkd.in/giEaftZe) team was excited today to hold our second Global Interactive Webinars (GIW) of 2025 with Jeffrey Raber, PhD. Below is the time/topic map, link and password to the Zoom webinar. I hope you enjoy it. We found it to be a very unique conversation. Best, The GEP team Link to Recording You can access the recording below: https://lnkd.in/gymZ2mrT Passcode: J#KAxz1! ? Time Map and Topics 0:00 – GEP Introduction 2:15 – Jeff Raber Introduction 4:00 – What is Organic chemistry? 4:30 – Adams, Mechoulam, Huffman and the Nobel Prize 8:15 – Biotech v. Cannabis science evolution 8:45 – Where is the science now? 12:00 – CBD Part II? 14:15 – Jeff and the coming Cannabis science 17:15 – Production now and the near-term 20:15 – More on form factors and consistency 22:30 – Finding the right products 23:00 – Characteristic for success
Talking Chemistry, Cannabinoids, & Innovation with Dr. Raber This Wednesday Golden Eagle Partners are extremely excited to welcome Jeffrey Raber, PhD to our webinar this Wednesday, February 26th 800 PT/900 MT/1100 ET/1700 CET. Dr. Raber is a distinguished organic chemist, researcher, and Cannabis industry pioneer with a deep expertise in botanical science, product development, and terpene innovation. Highlights of Jeff’s Impressive Career:? ?Founder & CEO of The Werc Shop, a leading Cannabis science and research lab. ?6 peer-reviewed publications and 15+ patents in Cannabis-related technologies. ? 2019 Researcher of the Year – Americans for Safe Access. ?Internationally recognized speaker on Cannabis science and innovation. ? We hope you can join us for an informative and succinct conversation! ?Register for the Webinar: ??https://lnkd.in/gtmRiPv6 #Cannabis #Cannabinoids #Innovation #GEPWebinar
Talking Chemistry, Cannabinoids and Innovation with Jeffrey Raber, PhD The Golden Eagle Partners (https://lnkd.in/giEaftZe) team would like to announce the second installment for 2025 of the Golden Eagle Partners (GEP) Global Interactive Webinar Series. The discussions are meant to integrate GEP’s over nine years of worldwide Cannabis expertise with perspectives from leaders from all over the globe into a lively and interactive 24-minute (4/20 backwards) discussion. Join us as we continue to cultivate insightful, thought-provoking discussions and meaningful collaboration. Register in advance for this webinar: ??https://lnkd.in/gtmRiPv6 #cannabinoids #Cannabis #chemistry
Golden Eagle Partners’ (GEP) Global Interactive Webinar with Nicole Brown David W. Traylor and Matthew Daugherty (https://lnkd.in/giEaftZe) were excited today to hold our first Global Interactive Webinar (GIW) of 2025 with Nicole Brown. Below is the time map, link and password to the Zoom webinar. I hope you enjoy it. We found it to be a very interesting conversation. Best, The GEP team Link to Recording You can access the recording below: https://lnkd.in/geFW6sQc Passcode: n&txhYC1 ? Time Map and Topics 0:00 – GEP Introduction 2:40 – Nic Brown Introduction 5:15 – Cannabinoids and the Endocannabinoid System 7:00 – Cannabinoids and functions and benefits 9:30 – Data, Information and Stigmas 10:00 – Cannabinoid Production – Methods and Processes 14:10 – Technology Push/Market Pull dynamics 16:30 – Talking Form Factors 21:00 – 2025 Cannabinoid Supply Chain 24:00 – Fun Fact/Characteristic for Success
GEP’s Global Interactive Webinars: A Conversation with Nicole Brown – Where are We Headed with Cannabinoids? The team at Golden Eagle Partners (https://lnkd.in/giEaftZe) would like to remind you of this week’s installment of the Golden Eagle Partners (GEP) Global Interactive Webinars (GIW) with Nicole Brown, a leader driving innovation with cannabinoids. Our Global Interactive Webinars are meant to leverage our global rolodex to converse with global leaders in Cannabis and psychedelics resulting in a concise and informative discussion. The webinar is scheduled for this Wednesday, February 12th at 800 PT/900 MT/1100 ET/1700 CET. Some of the topics that might come up tomorrow: ·??????How has cannabinoid production evolved? ·??????What is happening globally? ·??????What does the cannabinoid supply chain look like? ·??????What form factors look most interesting now in 2025? ·??????What role will intellectual property play with these molecules? Register in Advance After registering, you will receive a confirmation email containing information about joining the webinar. https://lnkd.in/gjBCdmev
The Golden Eagle Partners (GEP) Global Interactive Webinar (GIW) with Nicole Brown The Golden Eagle Partners (https://lnkd.in/giEaftZe) team would like to announce the first installment for 2025 of the Golden Eagle Partners (GEP) Global Interactive Webinar (GIW) Series. Our GIW series is meant to facilitate the dissemination of knowledge and wisdom from some of the leaders in the global Cannabis - both THC+ (MJ) and THC- (hemp) sector and also the psychedelic sector. The discussions are meant to integrate GEP’s over nine years of worldwide Cannabis expertise with leaders from all over the globe and from different areas of expertise – finance, legal, science, investment, operations, political, regulatory. Talking Cannabinoids with Nicole Brown Next week we are extremely excited to welcome Nicole Brown to our webinar next Wednesday, February 12th 800 PT/900 MT/1100 ET/1700 CET. Register for the Webinar Register in advance for this webinar: https://lnkd.in/gjBCdmev After registering, you will receive a confirmation email containing information about joining the webinar. Nicole Bio Nicole Brown is an innovation consultant with?subject matter expertise in Cannabis. ?Previously, Nicole served as Chief Innovation Officer for Open Book Extracts (OBX), a Cannabis ingredient manufacturer and product development house, supporting Cannabis MSOs and brands with new product development and commercial strategy. She is a strategic and data-driven operator with experience leading marketing, brand strategy, and 0-to-1 sales, with a passion for understanding and delighting customers. Prior to OBX, Nicole held marketing and brand strategy roles at LVMH, Shiseido, and TripAdvisor. She graduated from?Harvard University?with an honors degree in French Literature and a minor in Organic Chemistry. ? We hope you can join us for an informative and succinct conversation! #Cannabis #cannabinoids #innovation